Table of Content

1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency

2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for the study
2.5. Limitations for the study

3. Executive Summary

4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Government Initiatives Promoting Genetic Testing
4.2.2. Increasing Prevalence of Genetic Disorders
4.2.2.1. Sickle Cell Disease
4.2.2.2. Cystic Fibrosis
4.2.2.3. Down Syndrome and Neural Tube Defects
4.2.2.4. Parkinson’s Disease and Alzheimer’s Disease
4.2.2.5. Diabetes
4.2.3. Growing Need for the Early Detection & Prevention of Diseases
4.2.4. Increasing Applications of Genetic Testing in Oncology
4.2.5. Decreasing Costs of Sequencing Procedures
4.3. Restraints
4.3.1. High Cost of Genetic Testing in Low-Income Countries
4.3.2. Social and Ethical Implications of Genetic Testing
4.4. Opportunities
4.4.1. Growing Potential of Direct-To-Consumer Genetic Testing
4.4.2. Emerging Field of Genetic Counseling
4.5. Challenges
4.5.1. Low Chances of Positive, Actionable Mutations
4.5.2. Concerns Regarding the Security & Privacy of Genetic Data

5. Global Genetic Testing Market, by Offering
5.1. Introduction
5.2. Consumables & Reagents
5.3. Instruments
5.4. Services

6. Global Genetic Testing Market, by Test Type
6.1. Introduction
6.2. Prenatal Testing
6.3. Predictive and Presymptomatic Testing
6.4. Diagnostic Testing
6.5. Carrier Testing
6.6. Newborn Screening
6.7. Preimplantation Testing

7. Global Genetic Testing Market, by Method
7.1. Introduction
7.2. Molecular Tests
7.3. Chromosomal Tests
7.4. Biochemical Tests

8. Global Genetic Testing Market, by End User
8.1. Introduction
8.2. Hospitals and Clinics
8.3. Diagnostic Laboratories
8.4. Other End Users

9. Genetic Testing Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. Italy
9.3.3. France
9.3.4. U.K.
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.6. Middle East & Africa

10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis (2022)
10.4.1. Illumina, Inc.
10.4.2. Laboratory Corporation of America Holdings
10.4.3. Thermo Fisher Scientific Inc.
10.4.4. Myriad Genetics, Inc.
10.5. Competitive Dashboard
10.5.1. Industry Leaders
10.5.2. Market Differentiators
10.5.3. Vanguards
10.5.4. Emerging Companies

11. Company profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1. Thermo Fisher Scientific Inc.
11.2. Illumina, Inc.
11.3. Laboratory Corporation of America Holdings
11.4. Myriad Genetics, Inc.
11.5. Natera, Inc.
11.6. Perkinelmer Inc.
11.7. F. Hoffman-La Roche Ltd.
11.8. Centogene N.V.
11.9. Konica Minolta, Inc.
11.10. Opko Health, Inc.
11.11. Fulgent Genetics, Inc.

12. Appendix
12.1. Available Customization
12.2. Related Reports



List of Figures

List of Figures
Figure 1 Key Stakeholders
Figure 2 Research Process
Figure 3 Key Secondary Sources
Figure 4 Primary Research Techniques
Figure 5 Key Executives Interviewed
Figure 6 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 7 Market Size Estimation
Figure 8 Global Genetic Testing Market Size, by Offering, 2023 Vs. 2030 (USD Million)
Figure 9 Global Genetic Testing Market Size, by Test Type, 2023 Vs. 2030 (USD Million)
Figure 10 Global Genetic Testing Market Size, by Method, 2023 Vs. 2030 (USD Million)
Figure 11 Global Genetic Testing Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 12 Global Genetic Testing Market Size, by Geography
Figure 13 Market Dynamics: Genetic Testing Market
Figure 14 Number of Cancer Cases, by Region (2020)
Figure 15 U.S.: Increase in Cancer Cases (2017–2022)
Figure 16 Genome Sequencing Costs, 2010–2021 (USD/Genome)
Figure 17 Global Genetic Testing Market Size, by Offering, 2021 Vs. 2030 (USD Million)
Figure 18 Global Genetic Testing Market Size, by Test Type, 2021 Vs. 2030 (USD Million)
Figure 19 Global Genetic Testing Market Size, by Method, 2021 Vs. 2030 (USD Million)
Figure 20 Global Genetic Testing Market Size, by End User, 2021 Vs. 2030 (USD Million)
Figure 21 Global Genetic Testing Market, by Region, 2023 Vs. 2030 (USD Million)
Figure 22 North America: Genetic Testing Market Snapshot
Figure 23 Europe: Genetic Testing Market Snapshot
Figure 24 Germany: Estimated Cancer Incidence 2020 Vs. 2030 Percentage Distribution, by Age Group (0–44 Years)
Figure 25 Italy: Estimated Cancer Incidence 2020 Vs. 2030 Percentage Distribution by Age Group (0–44 Years)
Figure 26 France: Estimated Incidence In 2020 And 2030 by Cancer Percentage Distribution, by Age Group (0–44 Years)
Figure 27 Health Expenditure (2015–2020)
Figure 28 Asia-Pacific: Genetic Testing Market Snapshot
Figure 29 Number of New Cancer Cases, by Country/Region (2020)
Figure 30 Key Growth Strategies Adopted by Leading Players, 2019–2023
Figure 31 Genetic Testing Market: Competitive Benchmarking, by Offering
Figure 32 Genetic Testing Market: Competitive Benchmarking, by Region
Figure 33 Global Genetic Testing Market Share Analysis, by Key Players, 2022(%)
Figure 34 Competitive Dashboard: Genetic Testing Market
Figure 35 Thermo Fisher Scientific Inc.: Financial Overview (2021)
Figure 36 Illumina, Inc.: Financial Overview (2021)
Figure 37 Laboratory Corporation of America Holdings: Financial Overview (2021)
Figure 38 Myriad Genetics, Inc.: Financial Overview (2021)
Figure 39 Natera, Inc.: Financial Overview (2021)
Figure 40 Perkinelmer Inc.: Financial Overview (2021)
Figure 41 F. Hoffmann-La Roche Ltd.: Financial Overview (2021)
Figure 42 Centogene N.V.: Financial Overview (2021)
Figure 43 Konica Minolta, Inc.: Financial Overview (2021)
Figure 44 Opko Health, Inc.: Financial Overview (2021)
Figure 45 Fulgent Genetics, Inc.: Financial Overview (2021)